The Siemens Healthcare Diagnostics, Tarrytown, NY, DCA HbA1c test kit, already used to monitor diabetes patients’ HbA1c levels, has achieved the CE mark as an aid to diagnose diabetes and identify patients at risk for developing the disease.
Read More
As the population’s diabetes risk increases, the medical community looks at expanding glycemic testing for inpatients
Read MorePathway Genomics Corp, San Diego, has partnered with La Jolla, Calif, medical practice MD Revolution.
Read MoreJay M. Lieberman, MD, an expert in infectious diseases and emerging infectious diseases, is medical director of infectious diseases for Quest Diagnostics, Madison, NJ, and medical and laboratory director for Focus Diagnostics. CLP spoke with him about the West Nile virus outbreak.
Read MoreThe strategy consists of a risk assessment, followed, where necessary, by a blood test to confirm whether people have the disease, or are at high risk of developing it.
Read More